Cargando…

Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial

INTRODUCTION: A systemic anticoagulation is often required to prevent circuit and filter clotting in ICU patients undergoing continuous renal replacement therapy (CRRT). A regional citrate-based anticoagulation (RCA) does not induce a systemic anticoagulation and prolongs the filter lifespan, but me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stucker, Fabien, Ponte, Belen, Tataw, James, Martin, Pierre-Yves, Wozniak, Hannah, Pugin, Jérome, Saudan, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364313/ https://www.ncbi.nlm.nih.gov/pubmed/25881975 http://dx.doi.org/10.1186/s13054-015-0822-z

Ejemplares similares

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
por: Dickie, Helen, et al.
Publicado: (2015)

Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy
por: Bouchard, Josée, et al.
Publicado: (2009)

Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis
por: Qi, Wenqian, et al.
Publicado: (2023)

Use of high-volume haemodiafiltration in patients with refractory septic shock and acute kidney injury
por: Bourquin, Vincent, et al.
Publicado: (2013)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure
por: Rodriguez, Keila, et al.
Publicado: (2017)

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin
por: Burford, E, et al.
Publicado: (2015)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study
por: de Seigneux, Sophie, et al.
Publicado: (2012)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
por: Hu, Fang, et al.
Publicado: (2022)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Severe Leptospirosis with Multiple Organ Failure Successfully Treated by Plasma Exchange and High-Volume Hemofiltration
por: Bourquin, Vincent, et al.
Publicado: (2011)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Regional Citrate Anticoagulation and Systemic Anticoagulation during Pediatric Continuous Renal Replacement Therapy: A Systematic Literature Review
por: Buccione, Emanuele, et al.
Publicado: (2022)

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
por: Liu, Chao, et al.
Publicado: (2016)

Mathematical modelling of post-filter ionized calcium during citrate anticoagulated continuous renal replacement therapy
por: Forsal, Innas, et al.
Publicado: (2021)

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
por: Boer, Willem, et al.
Publicado: (2023)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
por: Sun, Yuelin, et al.
Publicado: (2023)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
por: Klingele, Matthias, et al.
Publicado: (2017)

Lessons for the clinical nephrologist: vascular access recirculation during continuous renal replacement therapy and regional citrate anticoagulation
por: Scherer, Patricia Faria, et al.
Publicado: (2022)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Filter life span in postoperative cardiovascular surgery patients requiring continuous renal replacement therapy, using a postdilution regional citrate anticoagulation continuous hemofiltration circuit
por: Kośka, Agnieszka, et al.
Publicado: (2022)

Simplified method of regional citrate anticoagulation for continuous extra renal epuration
por: Cointault, O, et al.
Publicado: (2002)

Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients
por: Link, Andreas, et al.
Publicado: (2012)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit
por: Davenport, Andrew, et al.
Publicado: (2009)

Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19
por: Khadzhynov, Dmytro, et al.
Publicado: (2022)

Citrate for continuous renal replacement therapy: safer, better and cheaper
por: Oudemans-van Straaten, Heleen M
Publicado: (2014)

Calcium-containing versus calcium-free replacement solution in regional citrate anticoagulation for continuous renal replacement therapy: a randomized controlled trial
por: Wei, Tiantian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rh6i1q8bsph8arckjhrc91tvcp